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Abstract
Background Two transcranial Doppler (TCD) estimators of cerebral arterial blood volume (CaBV) coexist: continuous outflow
of arterial blood outside the cranium through a low-pulsatile venous system (continuous flow forward, CFF) and pulsatile outflow
through regulating arterioles (pulsatile flow forward, PFF). We calculated non-invasive equivalents of the pressure reactivity
index (PRx) and the pulse amplitude index PAx with slow waves of mean CaBVand its pulse amplitude.
Methods About 273 individual TBI patients were retrospectively reviewed. PRx is the correlation coefficient between 30
samples of 10-second averages of ICP and mean ABP. PAx is the correlation coefficient between 30 samples of 10-second
averages of the amplitude of ICP (AMP, derived from Fourier analysis of the raw full waveform ICP tracing) and mean ABP.
nPRx is calculated with CaBV instead of ICP and nPAxwith the pulse amplitude of CaBVinstead of AMP (calculated using both
the CFF and PFF models). All reactivity indices were additionally compared with Glasgow Outcome Score (GOS) to verify
potential outcome-predictive strength.
Results When correlated, slowwaves of ICP demonstrated good coherence between slowwaves in CaBV (>0.75); slowwaves of
AMP showed good coherence with slow waves of the pulse amplitude of CaBV (>0.67) in both the CFF and PFF models. nPRx
was moderately correlated with PRx (R = 0.42 for CFF and R = 0.38 for PFF; p < 0.0001). nPAx correlated with PAxwith slightly
better strength (R = 0.56 for CFF and R = 0.41 for PFF; p < 0.0001). nPAx_CFF showed the strongest association with outcomes.
Conclusions Non-invasive estimators (nPRx and nPAx) are associated with their invasive counterparts and can provide mean-
ingful associations with outcome after TBI. The CFF model is slightly superior to the PFF model.
Keywords Cerebral autoregulation . Traumatic brain injury . Pressure reactivity index . Intracranial pressure . Transcranial
Doppler . Cerebral arterial blood volume
Introduction
The pressure reactivity index (PRx) is a common descriptor of
cerebrovascular reactivity (CVR) following traumatic brain
injury (TBI). PRx has become essential to patient prognosti-
cation, with negative or zero values of PRx indicative of fa-
vorable outcome and positive values indicative of poor out-
come [1]. Traditionally relying on the input from invasive,
continuous arterial blood pressure (ABP) and intracranial
pressure (ICP)monitors, PRx is considered to be an invasively
quantified surrogate marker of cerebral autoregulation (CA)
that accounts for changes in intracerebral blood volume attrib-
utable to either vasodilation or vasoconstriction [2].
The pulse amplitude index (PAx) is another index of cerebro-
vascular reactivity, which theoretically can outperform PRx
when the compliance of the cranial space is increased (i.e., after
craniectomy,with CSF leakages, etc.). It correlates the changes in
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the pulse amplitude of ICP (AMP) with changes in mean ABP
(as themoving correlation coefficient of 30 samples of 10-second
averages of AMP and mean ABP). Both PRx and PAx can be
only calculated when ICP is monitored. Since ICP monitoring
usually occurs over a few days or evenweeks after TBI, PRx and
PAx may be used for long-term management of patients (i.e.,
optimalcerebral perfusion pressure (CPP) -oriented therapy
[3–6]).
Indices of cerebral autoregulation can be calculated directly
with TCDmonitoring. Themean flow index (Mx) or the systolic
flow index (Sx) show stronger performance than PRx (the mov-
ing correlation coefficients of 30 samples of 10-second averages
of mean or systolic cerebral blood flow velocity (FV) and mean
cerebral perfusion pressure (CPP)) [7, 8]. However, TCD mon-
itoring is intermittent, (30 minutes to a few hours daily), whereas
ICP monitoring is continuous. This is associated with the diffi-
culty to maintain the continuous insonation of cerebral vessels
that is essential to the calculation of TCD indices; Sx andMx are
probably more accurate than PRx and PAx, but the latter indices
can be used continuously.
Changes in cerebral arterial blood volume can be calculated in
two ways. Equation 1 presumes that pulsatile inflow through the
basal arteries is equilibrated by non-pulsatile blood outflow
through the dural sinuses, creating the continuous flow forward
model (CFF). Equation 2 presumes that the inflow of arterial
blood is equilibrated by pulsatile flow forward through the reg-
ulating arterioles (the pulsatile flow forward model, PFF) [9].
ΔCaBVCFF tð Þ ¼ ∫
t
t0
CBFa sð Þ−meanCBFað Þds ð1Þ





where s is the arbitrary time variable of integration, CBFa is
cerebral blood flow, ABP is arterial blood pressure, andCVR is
cerebrovascular resistance [9].
There is great clinical interest in the application of non-
invasive metrics (particularly more accurate surrogate mea-
sures of PRx and PAx) during the subacute and long-term
phases of TBI care, where invasive ICP monitoring is no lon-
ger present and is thus unable to influence patient manage-
ment or contribute to traditional PRx and/or PAx evaluation.
Although the established Mx and Sx are TCD metrics of ce-
rebrovascular reactivity, they are in composition not true di-
rect surrogates of PRx and PAx, even if there is a moderate
correlation between them. The purpose of nPRx and nPAx is
to provide, as closely as possible, non-invasive measures for
PRx and PAx by modeling the constituent components of
invasively-derived PRx and PAx using noninvasive TCD-
based models of pulsatile CaBV as a direct surrogate for
ICP. Doing so provides nPRx and nPAx indices which are
more similar in method of derivation and physiologic compo-
sition than other TCD metrics (i.e., Mx and Sx).
This retrospective study seeks to explore the utility of
nPRx and nPAx (calculated with both the CFF and the
PFF models of CaBV) by correlating them with the
established cerebrovascular reactivity markers PRx and
PAx. As slow waves between ICP and CaBV are well-
synchronized (due to ICP pulsatility and CaBV modifi-
cations being triggered simultaneously during the cardiac
cycle), it was presumed that the CFF and PFF models
could evaluate cerebrovascular reactivity in the absence
of invasive ICP monitoring. A secondary aim of this
work is to correlate all of the aforementioned indices




About 273 severely head-injured patients (218 males and 55
females with an average age of 33 years [range: 3–77 years])
were admitted to the Neurosciences Critical Care Unit
(NCCU) at Addenbrooke’s Hospital, Cambridge, U.K., be-
tween 1992 and 2012. All patients were managed in accor-
dance with an ICP/CPP-oriented protocol designed to main-
tain ICP below 20 mm Hg. The exact protocol changed sev-
eral times over the monitoring period, but its essential compo-
nents were stable [10].
Monitoring
All patients underwent both invasive (ABP and ICP) and daily
non-invasive monitoring (TCD) while admitted to NCCU.
Raw data signals from select monitoring devices were record-
ed and electronically stored using WREC software (Warsaw
University of Technology) and ICM+ software (Cambridge
Enterprise, Cambridge, U.K.; http://www.neurosurg.cam.ac.
uk/icmplus).
ABP was continuously monitored both invasively
[from the radial artery using a pressure monitoring kit
(Baxter Healthcare C.A., U.S.A.; Sidcup, U.K.)] and
non i nva s i v e l y. ICP was mon i t o r e d u s i ng an
intraparenchymal probe with strain gauge sensors
(Codman & Shurtleff, M.A., U.S.A. or Camino
Laboratories, C.A., U.S.A.). Blood flow velocities were
monitored from the middle cerebral artery (MCA) with a
2 MHz probe (Multi Dop X4, DWL Elektronische
Systeme, Sipplingen, Germany). Raw TCD data
recordings were sampled within the entire patient cohort
(295 individual recordings) with an average continuous
monitoring duration of 35 minutes. Of the patients re-
ceiving multiple TCD monitoring sessions, all recordings
were utilized where signal quality was adequate. TCD
338 Acta Neurochir (2020) 162:337–344
measurements were intermittently performed anywhere
between the first 24 hours of admission and before final
removal of intraparenchymal ICP sensors. The exact pe-
riod and availability of TCD monitoring varied on an
individual basis.
This study was conducted as a retrospective analysis of a
prospectively-maintained database cohort, in which high-
frequency clinical neuromonitoring data had been archived.
The monitoring of brain modalities was conducted as a part
of standard Neurosciences Critical Care Unit (NCCU) patient
care using an anonymized database of physiological monitor-
ing variables in neurocritical care. Data on age, injury severity,
and clinical status at hospital discharge were recorded at the
time of monitoring on this database, and no attempt was made
to re-access clinical records for additional information (REC
97/291). Since all data was extracted from the hospital records
and fully anonymized, no data on patient identifiers were
available, and need for formal patient or proxy consent was
waived. Within our institution, patient data may be collected
with waiver of formal consent, as long as it remains fully
anonymized, with no method of tracing this back to an indi-
vidual patient. Patient physiologic, demographic, and out-
come data were collected by the clinicians involved with pa-
tient care and subsequently recorded in an anonymous format.
This anonymous data is then provided for future research pur-
poses. Such data curation remains within compliance for re-
search integrity as outlined in the U.K. Department of Health -
Governance Arrangements for Research Ethics Committees
(GAfREC), guidelines, section 6.0 [11].
Data processing
Processing of raw data signals utilized ICM+ software
(Cambridge Enterprise, Cambridge, U.K.; http://www.
neurosurg.cam.ac.uk/icmplus). Signal artifact removal was
first conducted with signal cropping tools within ICM+.
CPP was determined from the difference between raw ABP
and ICP signals.
Primary analysis involved the calculation of time-averaged
mean values for ABP, ICP, cerebral blood flow velocity (FV),
CPP, CaBV_CFF (according to Eq. 1, taking the FV signal
instead of CBF), and CaBV_PFF (according to Eq. 2, taking
the FV signal instead of CBF). Substituting CBF in Eqs. 1 and
2 with blood flow velocities has a consequence; estimators of
blood volume are presented as blood volume per 1 cm2 of cross-
sectional area of the vessel. Also, the arbitrary choice of t0 within
the calculation window of each interval containing 10 to 20
heartbeats produces the effect that only the relative changes of
cerebral arterial blood volume can be observed with the CaBV(t)
signals. The amplitudes of the fundamental frequencies of
CaBV_CFF and CaBV_PFF pulse waveforms (i.e., for a fre-
quency equivalent to heart rate) were also calculated as
AMP_CFF and AMP_PFF, respectively.
Mean values of the listed parameters were calculated during
10-second time windows and were updated every 10 seconds to
emphasize vasogenic slow wave fluctuations and to eliminate
overlap. A coherence module was calculated between series of
10-second averages of ICP and CaBV_CFF and CaBV_PFF in
the frequency band ranging from 0.005 to 0.05 Hz. The same
Table 1 Mean cerebral
hemodynamic parameters in TBI Parameter Mean Range Standard deviation
Age [years] 33.14 3.0–77.0 ± 15.96
Favorable: unfavorable outcome 132:122 1–5 –
Admission GCS (median) 6 1–15 IQR 4
ABP [mm Hg] 91.36 58.61–147.57 ± 12.08
ICP [mm Hg] 18.12 − 3.27-75.69 ± 9.92
CPP [mm Hg] 73.61 20.63–109.55 ± 13.20
FV [cm/s] 63.41 19.67–168.79 ± 25.64
PRx 0.02 − 0.65–0.96 ± 0.27
PAx − 0.10 − 0.93–0.76 ± 0.20
nPRx_CFF 0.16 − 0.41–0.80 ± 0.20
nPRx_PFF − 0.21 − 0.69–0.45 ± 0.19
nPAx_CFF − 0.07 − 0.45–0.56 ± 0.14
nPAx_PFF − 0.06 − 0.44–0.62 ± 0.13
ABP arterial blood pressure, CaBV_CFF cerebral arterial blood volume calculated with the continuous flow
forward method, CaBV_PFF cerebral arterial blood volume calculated with the pulsatile flow forward method,
cm/s centimeters per second, CPP cerebral perfusion pressure, Favorable: Unfavorable Outcome – Glasgow
Outcome Score [Favorable: GOS 4–5 (moderate-mild, or no disability); Unfavorable: GOS 1–3 (dead, vegetative
state, or severe disability)], FV cerebral blood flow velocity, Admission GCS - Glasgow Coma Score on admis-
sion, mm Hg millimeters of mercury, IQR interquartile range, nPRx_CFF non-invasive PRx calculated with the
continuous flow forward method, nPRx_PFF non-invasive PRx calculated with the pulsatile flow forward meth-
od, PAx pulse amplitude index, and PRx pressure reactivity index.
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calculations were applied to time series of AMP, AMP_CFF, and
AMP_PFF.
Final data processing involved the calculations from the pri-
mary analysis, with the addition of PRx (the correlation between
ABP and ICP), nPRx_CFF (the correlation between CaBV_CFF
and ABP), and nPRx_PFF (the correlation between CaBV_PFF
andABP). Non-invasive PAxwas calculated by correlating ABP
with either AMP_CFF or AMP_PFF (nPAx_CFF and
nPAx_PFF, respectively). Each of these parameters was calculat-
ed utilizing a 300-second time window, updated every
10 seconds.
Post-processing, all 10-second by 10-second data were
exported from each patient to separate comma-separated var-
iable (CSV) files for further statistical analysis.
Statistics
All statistical analyses were conducted utilizing R soft-
ware (R Core Team [2017]; R: a language and environ-
ment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria, URL https://
www.R-project.org/). Grand means of and descriptive
Fig. 1 Examples of good
synchronization of mean ICP and
CaBV time series in the frequency
range of slow waves (Fig. 1A).
Figure 1B demonstrates good
synchronization of the AMP time
series with AMP_CFF and AMP_
PFF
Table 2 Coherences between
variables within the frequency
range of 0.005–0.05 Hz
Variables Module of coherence
< 0.005–0.05 Hz >
95% Confidence intervals
ICP vs. CaBV_CFF 0.765 0.748–0.782
ICP vs. CaBV_PFF 0.758 0.741–0.776
AMP vs. AMP_CFF 0.73 0.718–0.747
AMP vs. AMP_PFF 0.678 0.665–0.692
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statistics for each parameter were calculated. Data were
normally distributed. Descriptive analyses were applied
to the coherences between ICP slow waves and CaBV
and between the AMP and AMP_CaBV series.
Linear regression techniques were employed to de-
scribe the following relationships in the entire cohort:
PRx vs. nPRx_CFF, PRx vs. nPRx_PFF, PAx vs.
nPAx_CFF, and PAx vs. nPAx_PFF. Goodness of fit
was reported utilizing the Pearson correlation coefficient
(R). Agreement between the parameters was assessed
with the Bland-Altman method.
Each of the above indices was also correlated with
dichotomized Glasgow Outcome Score (GOS) data (fa-
vorable vs. unfavorable outcome). Favorable outcome
was classified by GOS of 4 (moderate disability) and
5 (mild to no disability). Unfavorable outcome was clas-
sified by GOS of 1 (dead), 2 (vegetative state), or 3
(severe disability). The strength of the relationship be-
tween each index and outcome was reported via area
under the receiver operating curve (AUC), with bold
AUCs reaching p <0.05 (statistical significance identi-
fied by the DeLong test). p values between groups were
compared with t- and Mann-U tests.
Results
Table 1 summarizes descriptive statistics for the entire cohort
of TBI patients. Slow waves of ICP and CaBV in most cases
appeared well-synchronized in time (Fig. 1A, top panel). The
same observation can be made for time series of AMP,
AMP_CFF, and AMP_PFF (Fig. 1B, bottom panel). The av-
erage of the module of coherence functions in low frequency
limits (0.005 to 0.05 Hz) is presented in Table 2.
The correlations between PRx and nPRx and those be-
tween PAx and nPAx are only moderately strong (although
the R value is significantly non-zero at p <0.0001).
Scatterplots and correlation coefficients for each model (cal-
culated with either the CFF or PFF methods) are shown in
Fig. 2. Table 3 includes the results of Bland-Altman analysis
for invasive and non-invasive reactivity indices. The majority
of data points were clustered around the mean for each of the
modeled pairs with few outliers. It must be noted that the
outliers derived from the results shown in Fig. 2 are due to
the varying blood pressures exhibited by patients in the TBI
database.
Finally, all reactivity indices (invasive and non-invasive)
were compared in two outcome groups: favorable outcome
Fig. 2 Scatterplots of PRx vs.
nPRx and PAx vs. nPAx
calculated by the different CaBV
models. Pearson correlation
coefficients are given. The
correlation between PAx and
nPAx_CFF is significantly the
strongest (p <0.003). Correlations
between traditional parameters
and derived parameters based on
CFF models are stronger than
those based on PFF models (p





Critical difference Lower limit Mean difference Upper limit
PRx vs. nPRx_CFF 0.51 − 0.65 − 0.13 0.38
PRx vs. nPRx_PFF 0.52 − 0.28 0.24 0.76
PAx vs. nPAx_CFF 0.33 − 0.36 − 0.03 0.30
PAx vs. nPAx_PFF 0.40 − 0.44 − 0.03 0.37
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(n = 132) and unfavorable outcome (n = 122). About 19 pa-
tients were not available for follow-up. The strongest separa-
tion was detected for the nPAx_CFF index (Table 4).
nPAx_CFF performed the best when compared to outcome
but was not significantly different from the other indices when
evaluated with the DeLong test.
Discussion
In our evaluated population of TBI patients, nPRx and nPAx
calculated with the CFF model were found to better associate
with PRx and PAx. It is likely that the PFF model in general is
more susceptible to variations in its key components (i.e.,
unstable ABP in patients would affect the numerators in Eq. 2)
that impact its stability as a calculation method; this effect is
consistent with the findings of Eide et al. [12], which discovered
weak correlations between ABP and ICP pulse pressure ampli-
tudes and autoregulation indices such as PRx. On the basis of
their results [12], as the PFF model is comprised of input from
theABP signal, it is fitting that the nature of the nPRx_PFF index
is incompatible with PRx and PAx which are all “noisy” surro-
gate markers of cerebral autoregulation to begin with. The CFF
and PFFmodels partially account for total cerebral blood volume
change, as they are calculated as the difference between systolic
and mean cerebral blood flow integrated over a given period of
time. Cerebral blood flow velocity as assessed by TCD is a
surrogatemeasure of cerebral blood flow, as the TCDmonitoring
technique does not directly quantify cerebral circulation. Thus,
current applications of these models can only approximate cere-
bral blood volume change.
PRx ultimately responds to alterations in cerebral blood vol-
ume and responds to both ICP and ABP fluctuations as vessel
diameter changes. There is the additional possibility that PRx
may be inaccurately represented in TBI patients with either low
or high levels of ICP, as the index does not describe cerebrospinal
fluid compliance, which influences the direction of cerebral blood
volume change, and thus measured ICP3. As the nPRx and nPAx
indices do not rely on information from invasive ICP sensors but
rather ABP, they only moderately correlated with traditional PRx
and PAx, which are both more commonly associated with ICP. It
is important to note that the determination of nPRx and nPAx
with the current TCD-based CFF and PFF models cannot defin-
itively describe the relationships between the “true” inputs from
cerebral blood flow and either the ABP or the ICP signals.
Our no-ninvasive TCD models of PRx and PAx based on
CaBV estimates provide information closer to invasively de-
rived ICP. Further refinement of the nPRx_CFF model in par-
ticular will enhance the ability to non-invasively approximate
traditional PRx, which has been experimentally validated as a
measure of the lower limit of autoregulation [13]. nPRx can be
employed for long-term follow-up using continuous, non-
invasive ABP (via finger-cuff). Cerebrovascular reactivity
during the subacute phase of care can be correlated with
long-term autoregulatory status, inclusive of clinical pheno-
type and chronic neuroimaging changes (i.e., magnetic reso-
nance imaging (MRI)-based cortical atrophy or diffusion ten-
sor imaging (DTI) white matter tract volume). nPRx can in-
form clinicians of patient autoregulatory status in the absence
of neurosurgical placement of invasive monitors; it can be
directly calculated from emergency rooms or in remote hos-
pitals without neurosurgical services. Non-invasive determi-
nations of optimal cerebral perfusion pressure (nCPPopt) can
also benefit from nPRx, as PRx is a key component in the
visualization of CPP targets [6].
When comparing both traditional and derived autoregulation
indices with outcome, nPAx_CFF trended toward higher AUCs
in association with dichotomized 6-month outcomes. We must
acknowledge that TCD-based indices such as Mx and Sx and
both sets of nPRx and nPAx estimators can only be calculated if
patients receive TCDmonitoring, which is intermittently applied
at best; at present, it is difficult to provide continuousmeasures of
PRx or PAx in the absence of invasive monitoring. Traditional
TCD devices such as the DWL Multi Dop X4 require careful
placement of TCD probes that are both fragile and very easily
disturbed by small movements. Although emerging TCD tech-
nology with robotic-assisted probes allows for longer, uninter-
rupted TCD monitoring, these newer devices are ultimately less
Table 4 Differences between reactivity indices in patients with favorable and unfavorable outcomes at 6 months after TBI
Pressure Reactivity Index FAVORABLE UNFAVORABLE p value p value AUC
Mean and 95% CI Mean and 95% CI t-test Mann-U 95% CI
PRx −0.014 [−0.046;0.018] 0.189 [0.165;0.21] 0.022 0.078 0.564 [0.493–0.635]
nPRx_CFF 0.137 [0.113;0.161] 0.189 [0.165;0.21] 0.037 0.021 0.584 [0.514–0.654]
nPRx_PFF −0.242 [−0.26;-0.22] −0.018 [−0.21;-0.16] 0.013 0.015 0.601 [0.531–0.671]
PAx −0.134 [−0.159;-0.11] −0.055 [−0.08;-0.028] 0.018 0.002 0.615 [0.546–0.684]
nPAx_CFF −0.10 [−0.12;-0.085] −0.037 [−0.055;-0.019] 0.0003 0.0003 0.632 [0.564–0.701]
nPAx_PFF −0.076 [−0.09;-0.059] −0.052 [−0.069;-0.035] 0.164 0.093 0.561 [0.490–0.632]
The strength of the relationship between each index and outcome was additionally reported via area under the receiver operating curve (AUC), with bold
AUCs reaching p < 0.05.
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popular and too expensive for the majority of centers to obtain
for purely research purposes.
Limitations
The strength of our study is fundamentally limited by our reli-
ance on intermittent TCD recordings that were relatively short in
duration and susceptible to motion artifacts. Additionally, statis-
tical analyses were based on grand mean data, which reduces the
natural variability within the dataset and can potentially create
artificial effects. The correlation coefficient values are in a weak
to moderate range for strength. As such, the definitiveness of
conclusions from this current study is limited and should not be
extrapolated to other TBI populations at this time. Much further
multicenter investigation into nPRx and nPAx is required prior to
implementation as a clinical bedsidemeasure for cerebrovascular
reactivity. It is also worth noting that Mx and Sx have been
previously validated as having stronger outcome-predictive pow-
er than PRx [12], which we did not address in this study. The
rationale for nPRx and nPAx is somewhat artificial at the mo-
ment; these indices may become more clinically relevant when
the next generation of continuous TCD monitoring devices be-
comes available. There are differences between TCD-based auto-
regulation and pressure reactivity [14]; with better technology, it
may be useful to explore them jointly.
Conclusions
With TCD, it is possible to derive non-invasive estimators of
PRx and PAx based on cerebral blood volume modeling.
Direct clinical application of these non-invasive cerebrovas-
cular reactivity indices is limited by the current state of con-
tinuous TCD monitoring technologies, but following further
improvements on the auto-focusing of TCD probes and wave-
form visualization, they may become clinically useful.
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